Johnson & Johnson - 52 Year Stock Price History | JNJ
Historical daily share price chart and data for Johnson & Johnson since 1970 adjusted for splits. The latest closing stock price for Johnson & Johnson as of September 07, 2022 is 164.07.
- The all-time high Johnson & Johnson stock closing price was 183.61 on April 25, 2022.
- The Johnson & Johnson 52-week high stock price is 186.69, which is 13.8% above the current share price.
- The Johnson & Johnson 52-week low stock price is 155.72, which is 5.1% below the current share price.
- The average Johnson & Johnson stock price for the last 52 weeks is 170.25.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Johnson & Johnson Historical Annual Stock Price Data |
| Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
| 2022 |
171.3052 |
168.2332 |
183.6080 |
156.0979 |
164.0700 |
-2.21% |
| 2021 |
160.2115 |
149.6963 |
173.8124 |
147.3290 |
167.7723 |
11.45% |
| 2020 |
137.5422 |
135.8947 |
150.5380 |
104.1425 |
150.5380 |
10.85% |
| 2019 |
124.4005 |
116.5416 |
136.3323 |
114.6897 |
135.8016 |
15.35% |
| 2018 |
119.6900 |
123.6659 |
134.8690 |
107.5179 |
117.7275 |
-5.14% |
| 2017 |
113.8057 |
100.3016 |
126.9168 |
96.7688 |
124.1011 |
24.40% |
| 2016 |
97.0449 |
84.6156 |
107.1168 |
80.6324 |
99.7561 |
15.32% |
| 2015 |
82.7433 |
85.4708 |
88.6325 |
75.8499 |
86.5019 |
1.16% |
| 2014 |
81.3509 |
72.4325 |
88.7418 |
68.9234 |
85.5117 |
17.34% |
| 2013 |
67.2651 |
54.7096 |
76.0927 |
54.6324 |
72.8781 |
34.62% |
| 2012 |
50.7616 |
49.0731 |
55.5202 |
46.8748 |
54.1381 |
10.83% |
| 2011 |
46.4672 |
45.1497 |
49.6858 |
41.8164 |
48.8496 |
9.89% |
| 2010 |
43.8544 |
44.9003 |
46.1895 |
40.2517 |
44.4526 |
-0.58% |
| 2009 |
39.4800 |
40.7326 |
45.0947 |
31.5601 |
44.7129 |
11.28% |
| 2008 |
42.9532 |
43.0504 |
48.1237 |
37.1597 |
40.1819 |
-7.77% |
| 2007 |
41.2437 |
42.2906 |
44.6768 |
38.4378 |
43.5664 |
3.61% |
| 2006 |
39.1557 |
38.3469 |
43.7610 |
35.3416 |
42.0486 |
12.44% |
| 2005 |
39.8398 |
38.3769 |
42.5239 |
37.3576 |
37.3949 |
-3.36% |
| 2004 |
33.7856 |
30.9142 |
38.9016 |
29.7518 |
38.6942 |
25.17% |
| 2003 |
31.1933 |
32.5345 |
34.6363 |
29.0271 |
30.9142 |
-2.11% |
| 2002 |
33.6542 |
34.0509 |
38.1091 |
24.4340 |
31.5819 |
-7.88% |
| 2001 |
29.9406 |
29.1937 |
35.3677 |
23.9081 |
34.2830 |
13.97% |
| 2000 |
25.4291 |
26.0769 |
30.0809 |
19.4460 |
30.0809 |
14.04% |
| 1999 |
26.4567 |
23.1216 |
30.0114 |
21.5306 |
26.3767 |
12.46% |
| 1998 |
20.8527 |
17.9573 |
24.8860 |
17.6648 |
23.4544 |
28.99% |
| 1997 |
16.3544 |
13.5387 |
18.4762 |
13.5387 |
18.1837 |
34.31% |
| 1996 |
13.1098 |
11.2952 |
14.6272 |
11.2952 |
13.5387 |
18.11% |
| 1995 |
9.1535 |
7.1699 |
12.2672 |
7.0713 |
11.4628 |
59.14% |
| 1994 |
6.0141 |
5.8100 |
7.3186 |
4.7481 |
7.2028 |
24.99% |
| 1993 |
5.3266 |
6.2024 |
6.2024 |
4.5472 |
5.7625 |
-8.93% |
| 1992 |
6.1286 |
6.9070 |
7.1611 |
5.3539 |
6.3277 |
-10.19% |
| 1991 |
5.4724 |
4.2340 |
7.1069 |
3.9691 |
7.0454 |
62.34% |
| 1990 |
3.7643 |
3.5470 |
4.3939 |
3.0802 |
4.3399 |
23.39% |
| 1989 |
2.9345 |
2.4225 |
3.5173 |
2.4225 |
3.5173 |
42.63% |
| 1988 |
2.3170 |
2.2080 |
2.5372 |
1.9887 |
2.4660 |
16.52% |
| 1987 |
2.4186 |
1.8768 |
2.9411 |
1.8133 |
2.1164 |
15.80% |
| 1986 |
1.7572 |
1.4142 |
2.0472 |
1.3016 |
1.8277 |
27.42% |
| 1985 |
1.1982 |
0.9440 |
1.4925 |
0.9307 |
1.4344 |
49.85% |
| 1984 |
0.8922 |
1.0465 |
1.0849 |
0.7354 |
0.9572 |
-8.53% |
| 1983 |
1.1547 |
1.2378 |
1.2792 |
1.0048 |
1.0465 |
-15.66% |
| 1982 |
1.0100 |
0.8939 |
1.2753 |
0.7980 |
1.2408 |
36.94% |
| 1981 |
0.8231 |
0.7921 |
0.9272 |
0.6913 |
0.9061 |
14.54% |
| 1980 |
0.6211 |
0.5920 |
0.7931 |
0.5165 |
0.7911 |
29.41% |
| 1979 |
0.5485 |
0.5570 |
0.6171 |
0.4959 |
0.6113 |
10.48% |
| 1978 |
0.5699 |
0.5504 |
0.6621 |
0.4864 |
0.5533 |
-1.76% |
| 1977 |
0.5113 |
0.5617 |
0.5632 |
0.4527 |
0.5632 |
0.41% |
| 1976 |
0.6171 |
0.6402 |
0.6837 |
0.5177 |
0.5609 |
-12.03% |
| 1975 |
0.6292 |
0.5841 |
0.7001 |
0.5190 |
0.6376 |
12.02% |
| 1974 |
0.6905 |
0.7803 |
0.8326 |
0.5274 |
0.5692 |
-27.70% |
| 1973 |
0.8282 |
0.8933 |
0.9072 |
0.7297 |
0.7873 |
-13.22% |
| 1972 |
0.8185 |
0.6770 |
0.9178 |
0.6570 |
0.9072 |
32.98% |
| 1971 |
0.5882 |
0.3944 |
0.6848 |
0.3944 |
0.6822 |
73.72% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$429.030B |
$93.775B |
|
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
|
